EUVIMEDEUVIMED entdecken
Open Access

Fibroblast growth factor 13 deficiency attenuates doxorubicin-induced cardiotoxicity by regulating Parkin-mediated myocardial injury

Jiabing Han, Xuyan Li, Yiming Dong, Yidan Wang, Simeng Lv, Yiyi Zhang, Ran Zhao, Yingke Yan, Yanxue Han, Yu Wang, Jing Yang, Cong Wang und 1 weitere

Acta Biochimica et Biophysica Sinica · 2026

DOI: 10.3724/abbs.2025223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2026. Verfasst von Jiabing Han und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of New Drug Pharmacology and Toxicology, Hebei Medical University, Shijiazhuang 050017, China. Hauptthemen laut MEDLINE: Doxorubicin, Fibroblast Growth Factors, Ubiquitin-Protein Ligases, Cardiotoxicity. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinFibroblast Growth FactorsUbiquitin-Protein LigasesCardiotoxicityAnimalsMiceMyocytes, CardiacMice, Inbred C57BLApoptosisMice, KnockoutMale

Stichwörter der Autor:innen

Keywords: FGF13Parkinapoptosiscardiotoxicitymyocardial injury

Substanzen

DoxorubicinFibroblast Growth FactorsUbiquitin-Protein Ligasesfibroblast growth factor 13parkin protein

Autor:innen und Institutionen

  • The Key Laboratory of New Drug Pharmacology and Toxicology, Hebei Medical University, Shijiazhuang 050017, China.
  • College of Basic Medical Science, Hebei University, Baoding 071000, China.
  • Zhejiang Key Laboratory of Medical Epigenetics, Hangzhou Normal University, Hangzhou 310000, China.
  • Department of Pathology and Pathophysiology, Hangzhou Normal University, Hangzhou 310000, China.
  • Editorial Department of Hebei Medical University, Hebei Medical University, Shijiazhuang 050017, China.
  • Central Laboratory, Affiliated Hospital of Hebei University, Clinical Medical College, Hebei University, Baoding 071000, China.

Zitieren

APA

Han, J., Li, X., Dong, Y., Wang, Y., Lv, S., Zhang, Y., Zhao, R., Yan, Y., Han, Y., Wang, Y., Yang, J., Wang, C., & Wang, C. (2026). Fibroblast growth factor 13 deficiency attenuates doxorubicin-induced cardiotoxicity by regulating Parkin-mediated myocardial injury. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025223

Vancouver

Han J, Li X, Dong Y, Wang Y, Lv S, Zhang Y, et al. Fibroblast growth factor 13 deficiency attenuates doxorubicin-induced cardiotoxicity by regulating Parkin-mediated myocardial injury. Acta Biochimica et Biophysica Sinica. 2026. doi:10.3724/abbs.2025223

BibTeX
@article{Han2026,
  author = {Han, Jiabing and Li, Xuyan and Dong, Yiming and Wang, Yidan and Lv, Simeng and Zhang, Yiyi and Zhao, Ran and Yan, Yingke and Han, Yanxue and Wang, Yu and Yang, Jing and Wang, Cong and Wang, Chuan},
  title = {Fibroblast growth factor 13 deficiency attenuates doxorubicin-induced cardiotoxicity by regulating Parkin-mediated myocardial injury},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2026},
  doi = {10.3724/abbs.2025223}
}
Kostenlos starten →